These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 12483536)
1. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Devarajan E; Sahin AA; Chen JS; Krishnamurthy RR; Aggarwal N; Brun AM; Sapino A; Zhang F; Sharma D; Yang XH; Tora AD; Mehta K Oncogene; 2002 Dec; 21(57):8843-51. PubMed ID: 12483536 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Végran F; Boidot R; Oudin C; Riedinger JM; Bonnetain F; Lizard-Nacol S Clin Cancer Res; 2006 Oct; 12(19):5794-800. PubMed ID: 17020986 [TBL] [Abstract][Full Text] [Related]
3. Caspase expression profile and functional activity in a panel of breast cancer cell lines. Yang S; Liu J; Thor AD; Yang X Oncol Rep; 2007 May; 17(5):1229-35. PubMed ID: 17390070 [TBL] [Abstract][Full Text] [Related]
4. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Yang XH; Sladek TL; Liu X; Butler BR; Froelich CJ; Thor AD Cancer Res; 2001 Jan; 61(1):348-54. PubMed ID: 11196185 [TBL] [Abstract][Full Text] [Related]
5. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Winter RN; Kramer A; Borkowski A; Kyprianou N Cancer Res; 2001 Feb; 61(3):1227-32. PubMed ID: 11221855 [TBL] [Abstract][Full Text] [Related]
7. Caspase 3 in breast cancer. O'Donovan N; Crown J; Stunell H; Hill AD; McDermott E; O'Higgins N; Duffy MJ Clin Cancer Res; 2003 Feb; 9(2):738-42. PubMed ID: 12576443 [TBL] [Abstract][Full Text] [Related]
8. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268 [TBL] [Abstract][Full Text] [Related]
9. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Kazhdan I; Marciniak RA Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201 [TBL] [Abstract][Full Text] [Related]
10. Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. Chen JS; Konopleva M; Andreeff M; Multani AS; Pathak S; Mehta K J Cell Physiol; 2004 Aug; 200(2):223-34. PubMed ID: 15174092 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Runnebaum IB; Brüning A Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Friedrich K; Wieder T; Von Haefen C; Radetzki S; Jänicke R; Schulze-Osthoff K; Dörken B; Daniel PT Oncogene; 2001 May; 20(22):2749-60. PubMed ID: 11420687 [TBL] [Abstract][Full Text] [Related]
13. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related]
14. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells. Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850 [TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Hu Y; Cherton-Horvat G; Dragowska V; Baird S; Korneluk RG; Durkin JP; Mayer LD; LaCasse EC Clin Cancer Res; 2003 Jul; 9(7):2826-36. PubMed ID: 12855663 [TBL] [Abstract][Full Text] [Related]
16. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Pingoud-Meier C; Lang D; Janss AJ; Rorke LB; Phillips PC; Shalaby T; Grotzer MA Clin Cancer Res; 2003 Dec; 9(17):6401-9. PubMed ID: 14695141 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein. Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492 [TBL] [Abstract][Full Text] [Related]
18. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways. Park SJ; Wu CH; Safa AR Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. Puca R; Nardinocchi L; Pistritto G; D'Orazi G Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248 [TBL] [Abstract][Full Text] [Related]
20. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]